U.S. Markets close in 2 hrs 2 mins

International Stem Cell Corporation (ISCO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.5105-0.0595 (-10.44%)
As of 1:15PM EDT. Market open.
Sign in to post a message.
  • D
    DDD
    Awesome news from an ISCO patient in Australia. I have tried to follow Kevin Weeks progress:
    (June 13, 2019) "Normally, people with Parkinson’s Disease become progressively worse, so for my condition to actually be improving is an amazing result,” Weeks said
    Still improving 2 years later !
    https://www.thebend.com.au/news/inspirational-south-aussie-makes-racing-return-gt1
  • A
    Anonymous
    ISCO seeks products that alleviate suffering, but also have an operational business side that appears to be stable and slowly growing. It generates both revenue and experience in the mechanics and logistics of a functional producing business They made it to Phase I Human Studies for intracranial transplantation of stem cell derived neural cells and the results are both good and encouraging, a major achievement they are not being properly recognized for.

    They look to be reaching a Phase II level in the near future. Often it is said biotech industry new start companies are not even looked at until they are in Phase II. Some time into Phase II, especially if the operating units continue to expand and provide income, recognition will have to come. The thing that has always impressed my about ISCO is that they seem to eventually do most of what they say they are going to. The thing that has bothered me the most is how low their cash reserves always ran. The chief insiders always kept it going by diluting, but putting their money in to do it. That seems to be doing the needed thing with confidence. It was nice to see the half million dollar investment purchase of new shares the other day. It added shares, but was not really dilutive since it went for $1.75, which was greater than open market share values. Still not too much dilution in this latest particular part of the company's phase. Outstanding shares could effectively be already in the pipeline at somewhere around 30 million shares. If that stayed the same and the operating units continue to grow and expand, and Phase II gets going sooner than later, and Phase II shows good results, the company could be worth 500 million market cap. That is $16.67 per share. Lots of ifs and whens, but this looks some kind of positive from here. you never know so it is just my opinion and hope.
  • J
    Joshua
    So much potential here! Wish they would partner with a big pharma company to get the trials to go faster. Could be a a major game changer for a lot of people who are suffering.
  • J
    Joshua
    Is this company ever going to tell us anything again? Been waiting for some news forever!
  • A
    Anonymous
    Technology is not a farce. Such statements are BS. The only legitimate critique I have found is they do not have a lot of peer reviewed papers and have a one year evaluation period for the patients. That it really takes 2-3 years to fully evaluate improvements with such procedures, based on evidence that it takes some time for cell survival to start producing dopamine on their own. If we see later evaluation periods showing improvement during the so called 'off periods' then they really have something great and it will become obvious. But the simple fact of successful intracranial transplantation of neural cells at a renowned neuroscience medical center is about as far from a farce as one can be. I dont mind if someone is not an investor in a stock for some reason, but spewing negativity with short bursts of 'fraud' or 'farce' statements is also about as disingenuous as it gets. I can't promise ISCO will ultimately be successful, but a fraud or farce they are not!
  • A
    Alexander
    Second cohort of dosing report sounds successful----can't wait for the third cohort to get completed!
  • H
    Huge
    Lets see if we can keep this going tomorrow!!
  • A
    Anonymous
    Latest 2018 1st quarter report looks good in terms of improved revenue and lower cash burn. They continue to slowly climb in the right direction. This is a unique company with real products and revenue to help fund R&D and clinical studies. Rather rare actually. Nice to see clinical stages progressing rapidly as well.
  • H
    Huge
    A ton of volume today and a nice little jump on zero news!
  • H
    Huge
    CEO buys $3.3million on shares in early Dec, exciting news about Weeks today....on the road to success for all.
  • H
    Huge
    Holy Moly!!!!
  • p
    patrick
    87% insider ownership! Sounds like they are putting there money where there mouth is ! If the stock does bad it’s out of there pocket and it sounds like they expect the company to do great by them owning so much of the stock! I will watch
  • H
    Huge
    This is awesome news!!!!!! This @#$!&@# is for REAL!!!
  • M
    Moses
    i think its still overpriced currently
  • J
    JF
    I thought this was a superconductivity company last time I looked..
  • c
    cbachand
    jf that is ASCO American superconductor.
  • p
    patrick
    I may have to get in here!!
  • P
    Peter j.
    We seem to be “Off To The Races” again.
  • G
    Gary
    Anyone got a reason for today's uptick??
  • I
    IPA
    Bwahahahaha!!!! What a loser this company is. Absolutely useless!!